Journal of Cancer Prevention 2013; 18(2): 177-185
Published online June 30, 2013
https://doi.org/10.15430/JCP.2013.18.2.177
© Korean Society of Cancer Prevention
Bo-Min Kim1, Do-Hee Kim1, Jeong-Hill Park1, Hye-Kyung Na2, and Young-Joon Surh1
1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 2Department of Food and Nutrition, Sungshin Women’s University, Seoul, Korea
Correspondence to :
Young-Joon Surh, College of Pharmacy, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82-2-880-7845, Fax: +82-2-872-1795, E-mail: surh@snu.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background:
Rg3, a major ginsenoside derived from heat-processed ginseng, has been reported to have anti-inflammatory and anti-proliferative activities. In our previous studies, Rg3 inhibited phorbol ester-induced cyclooxygenase-2 expression and NF-κB activation in cultured human mammary epithelial (MCF-10A) cells and in mouse skin
Methods:
After Rg3 treatment, apoptotic cell death of MDA-MB-231 cell was investigated by the MTT reduction assay and measurement of the mitochondrial membrane depolarization. Flow cytometry was used for cell cycle analysis and detection of apoptotic cells as well as measurement of reactive oxygen species. Expression of apoptotic-related proteins was determined by immunoblot analysis.
MDA-MB-231 cells treated with Rg3 (30
Based on these findings, it is likely that Rg3 induces apoptosis in MDA-MB-231 cells via classical mitochondria-dependent caspase activation. These data suggest that Rg3 might be a potential candidate as a breast cancer chemopreventive agent.
Keywords: Ginsenoside, Rg3, Apoptosis, Breast cancer, MDA-MB-231 cells
A large number of phytochemicals present in fruits and vegetables or in medicinal plants have been found to retain potential cancer chemopreventive activities.1?4 Ginseng has long been used as a herbal drug in traditional oriental medicine and is now used extensively as a general health supplement. According to an epidemiological study conducted in Korea, chronic intake of ginseng has been associated with a decreased incidence of cancers, such as esophageal, gastric, colorectal, and pulmonary tumors.5?7 Components that have been isolated and characterized from ginseng include ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids.8 Among these, ginsenosides are major pharmacologically active ingredients that have been shown to have anti-oxidation, anti-inflammation, and anti-carcinogenic activities.9,10 It has been reported that heat-treatment of ginseng potentiates its biological activity, and Rg3 is one of the major ingredients in heat-processed ginseng.11,12
Generally, the growth rate of pre-neoplastic or malignant cells outpaces that of normal cells because of malfunctioning or deregulation of their cell-growth and cell-death machineries.13 The normal cell function and tissue homeostasis are maintained by a balance between proliferation and apoptosis. Cancer is a typical disorder in which clones of malignant cells escape such balance and proliferate inappropriately without compensatory apoptosis.14 The success of cancer therapies greatly relies on the extent to which they preferentially induce tumor cell death while allowing survival of normal cells. In this context, induction of apoptosis is recognized as a rational approach to eliminate genetically damaged or pre-neoplastic cells before any malignancy manifests.
Our previous studies have demonstrated that the methanol extract of the heat-processed
Rg3 was prepared and purified as described previously.11
2. Cell culture
MDA-MB-231 cells were grown at 37°C in DMEM supplemented with 10% heat-inactivated fetal bovine serum in a humidified atmosphere of 5% CO2 and 95% air. Cells were plated at an appropriate density according to the scale of each experiment, and the medium was changed at 2-day intervals.
3. Measurement of cell viability
Cell viability was determined by employing the conventional MTT reduction assay. After incubation with Rg3, cells were treated additionally with MTT solution (0.5 mg/ml final concentration) for 2 h at 37°C. Viable cells convert the internalized MTT to insoluble blue formazan crystals by reduction catalyzed by mitochondrial dehydrogenase (e.g., succinate dehydrogenase). The dark blue formazan crystals formed within mitochondria of surviving cells were dissolved by addition of DMSO, and the absorbance of blue color was measured using a microplate reader set at 570 nm (Molecular Devices, Sunnylvale, CA, USA). Cell viability was expressed as the percentage of MTT reduction obtained in the Rg3-treated cells, assuming the absorbance of control cells was 100%.
4. Determination of apoptotic cells (cell cycle analysis)
MDA-MB-231 cells (2×105 cells/well) were seeded onto 6 well plates and treated with the test drugs for the indicated times. Harvested cells were fixed overnight in 70% ethanol at 4°C, then collected by centrifugation and resuspended in phosphate-buffered saline (PBS) containing 25
5. Detection of apoptosis by annexin V/PI staining
MDA-MB-231 cells treated with Rg3 for 24 h and then stained with annexin V conjugated to FITC (fluorescein isothiocyanate) and propidium iodide with an annexin V-FITC apoptosis detection kit (BD Biosciences) according to the manufacturer’s protocol. Briefly, cells were suspended in 100
6. Measurement of mitochondrial transmembrane potential (
To measure the
7. Measurement of intracellular reactive oxygen species (ROS) accumulation
To monitor the intracellular accumulation of ROS, the fluorescent probe DCF-DA was used. Following treatment, cells were rinsed with Kreb’s ringer solution and 10
8. Western blot analysis
MDA-MB-231 cells were lysed in RIPA lysis buffer [150 mM NaCl, 0.5% TritonX100, 50 mM Tris-HCl (pH 7.4), 25 mM NaF, 20 mM EDTA, 1 mM dithiothreitol (DTT), 1 mM Na3VO4, and protease inhibitor] for 30 min at 0°C followed by centrifugation at 12,000×g for 15 min. The protein concentration of the supernatant was measured by using the BCA reagent (Pierce, Rockfold, IL, USA). Protein (40
When MDA-MB-231 cells were treated with Rg3 for 24 h, the cell viability declined in a concentration-dependent manner (Fig. 1A). For quantitative assessment of the induction of apoptosis by Rg3, we measured the proportion of cells in the sub-G1 phase by flow cytometric analysis. As shown in Fig. 1B, treatment of the cells with 30
To elucidate the mechanisms underlying the pro-apoptotic effects of Rg3, the expression of several major apoptosis regulators was measured by Western blot analysis. The ratio of pro-apoptotic Bax and the anti-apoptotic Bcl-2 is considered as a molecular rheostat determining cell survival/death.18 As shown in Fig. 3A, Rg3 treatment led to a concomitant decrease in the level of Bcl-2, whereas the expression of Bax remained unchanged. Caspases are important mediators of apoptosis and contribute to the overall apoptotic morphology by cleavage of various cellular substrates. PARP, a known caspase substrate, is a 116-kDa nuclear protein that is specifically cleaved by active caspase-3 into an 85-kDa apoptotic fragment.19 When MDA-MB-231 cells were treated with Rg3 for 24 h, the cleavage of both caspase-3 and PARP increased (Fig. 3B). However, when co-treated with z-VAD-fmk, the caspase-3 inhibitor, cytotoxicity (Fig. 4A) and cleavage of caspase-3 and PARP induced by Rg3(Fig. 4B) were abrogated.
Dysregulation of cellular redox status can be a potent mechanism of cell death. Several studies have implicated ROS generation as a plausible mechanism for induction of apoptosis by various anticancer agents.20 Therefore, we tested the possible involvement of ROS in Rg3-induced apoptosis. Fluorescent microscopy and fluorescence-activated cell sorting (FACS) increased generation of ROS in MDA-MB-231 cells following treatment with Rg3 for 2 to 3 h (Fig. 5A and B). To determine whether Rg3-induced ROS accumulation could mediate induction of apoptosis, MDA-MB-231 cells were treated with NAC and trolox which are prototype ROS scavengers. Inhibition of Bcl-2 expression and cleavage of caspase-3 as well as cell viability by Rg3 treatment were only partially blocked when NAC or trolox was added to the medium (Fig. 5C and D).
Ginseng is a valuable agricultural commodity grown for use in many traditional medicinal therapies. More contemporary utilization of ginseng includes formulations prepared for herbal supplements or in functional foods; certain ginsenosides also have therapeutic potential and may be utilized for drug development.21 Ginsenosides possess a common triterpene structure in the backbone and have a structural diversity. So far, about 35 kinds of ginsenosides have been isolated from fresh, white or red ginseng, among which 22 kinds of ginsenosides are the protopanaxadiol type and 12 of them are the protopanaxatriol type, and only one ginsenoside Ro is an oleanane type.8 Although the extracts from fresh or processed
In the present study, we investigated the proapoptotic effects of Rg3, one of the major ingredients of heat-processed ginseng, in MDA-MB-231 cells. Caspases are recognized as important mediators of apoptosis. Once the caspases become active, they exert the apoptotic effects in part by autoactivation, thereby cleaving substrates, such as another caspase or PARP, that are critical for cell survival.23,24 For Rg3-induced apoptosis of MDA-MB-231 cells, it is likely that caspase-3 is activated, which results in the degradation of the DNA repair enzyme PARP. The ratio of pro-apoptotic Bax and the anti-apoptotic Bcl-2 is considered a molecular rheostat determining cell survival/death.25 In our study, the ratio of pro-apoptotic Bax and the anti-apoptotic Bcl-2 was decreased in MDA-MB-231 cells treated with Rg3.
Moderate amounts of ROS can act as mediators of intracellular signaling cascades. However, excessive production of ROS can cause oxidative stress, loss of cell function, and ultimately apoptosis or necrosis. Our results indicate that treatment of MDA-MB-231 cells with Rg3 led to a transient increase of intracellular ROS, which was followed by a reduced ratio of Bcl-2/Bax expression, disruption of the mitochondrial transmembrane potential leading to the activation of the caspase 9/3 cascade. We intended to see whether ROS generation is an upstream event of Rg3-induced mitochondrial membrane damage and apoptosis in our model. Our studies revealed that co-treatment of NAC or trolox resulted in only marginal protection against Rg3-induced apoptosis in MDA-MB-231 cells. These findings imply that ROS-induced oxidative stress does not appear to be a major mechanism underlying Rg3-induced apoptosis of MDA-MB-231 cells.
In conclusion, Rg3 induced apoptosis in human breast cancer (MDA-MB-231) cells, which is mediated by the activation of the mitochondrial death pathway.
Seung-Yeon Oh, Eun-Ju Lee and Mi-Kyung Sung
Cancer prevention research 2009; 14(2): 104-110Jihae Han, Jung-Hyun Kim, Gwang-Mo Yang and Ssang-Goo Cho
Cancer prevention research 2012; 17(4): 288-294Yanymee N. Guillen-Quispe, Su-Jung Kim, Soma Saeidi, Gyo-Jin Choi, Chaithanya Chelakkot, Tianchi Zhou, Sang-Beom Bang, Tae-Won Kim, Young Kee Shin, Young-Joon Surh
J Cancer Prev 2024; 29(4): 129-139 https://doi.org/10.15430/JCP.24.031